Why the study?
Does exogenous Thymosin β4 reduce cardiac damage and fibrosis in mice with myocardial infarction?
Population
Mice with ligation-induced AMI, and mouse cardiac myocytes and myofibroblasts
Comparison
Intraperitoneal AAV-Tβ4 or exogenous Tβ4 vs controls
Design
In vivo mouse and in vitro preclinical study
Authors
Loading...
Hypothesis-generating for Tβ4 in experimental MI; leaves open translation to human cardioprotection.
Does exogenous Thymosin β4 reduce cardiac damage and fibrosis in mice with myocardial infarction?
Exogenous Thymosin β4 supplementation protects against cardiac damage and fibrosis following myocardial infarction in mice by reducing oxidative stress and promoting mitophagy.
Wang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: